This resolution expresses support for designating September 2026 as National Ovarian Cancer Awareness Month. The measure highlights that ovarian cancer is the fifth-leading cause of cancer deaths among women in the United States, with an estimated 20,010 new cases and 12,450 deaths expected in 2026, and notes that about 80 percent of cases are detected at advanced stages because there is no reliable early detection test. The resolution emphasizes significant health disparities, particularly among Black women and women of color who experience lower survival rates and face systemic barriers to quality care, and calls attention to the need for greater public awareness of vague symptoms like bloating and abdominal pain that could lead to earlier diagnosis. The measure also underscores the importance of genetic testing and counseling, especially for women with family history or hereditary risk factors like BRCA gene mutations, and advocates for increased federal investment in ovarian cancer research and education. No funding is authorized by this resolution, which is a symbolic measure expressing congressional support for raising awareness about the disease during September 2026.